Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MAPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MIR664B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C1GALT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSPAN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NECAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VPS45 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CETN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF75D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ORMDL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTF2E2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATXN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BID - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VMA21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on